Sean I. Savitz, MD | McGovern Medical ...

Dr. Sean Savitz

Claim this profile

The University of Texas Health Science Center at Houston

Expert in Stroke
Studies Peripheral Neuropathy
13 reported clinical trials
19 drugs studied

Affiliated Hospitals

Image of trial facility.
The University Of Texas Health Science Center At Houston
Image of trial facility.
Memorial Hermann-Texas Medical Center

Clinical Trials Sean Savitz is currently running

Image of trial facility.

Transcranial Magnetic Stimulation

for Stroke

VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, transmagnetic stimulation (TMS), and MRI measures in the acute stroke time window.
Recruiting1 award N/A6 criteria
Image of trial facility.

Cognitive Outcomes

for Stroke

The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking and other mental abilities that significantly affects daily functioning) after their stroke so that future treatments may be developed to improve outcomes in stroke patients. For this study, a "stroke" is defined as either (1) an acute ischemic stroke (AIS, or blood clot in the brain), (2) an intracerebral hemorrhage (ICH, or bleeding in the brain), (3) or an aneurysmal subarachnoid hemorrhage (aSAH, or bleeding around the brain caused by an abnormal bulge in a blood vessel that bursts). The investigators hypothesize that: 1. The size, type and location of the stroke play an important role in recovery of thinking and memory abilities after stroke, and pre-existing indicators of brain health further determine the extent of this recovery. 2. Specific stroke events occurring in individuals with underlying genetic or biological risk factors can cause further declines in brain heath, leading to changes in thinking and memory abilities after stroke. 3. Studying thinking and memory alongside brain imaging and blood samples in patients who have had a stroke allows for earlier identification of declining brain health and development of individualized treatment plans to improve patient outcomes in the future.
Recruiting1 award N/A6 criteria

More about Sean Savitz

Clinical Trial Related4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Sean Savitz has experience with
  • NCS-01
  • Placebo
  • IntenSive UpPer Extremity Recovery Program
  • I-ACQUIRE - High Dosage
  • I-ACQUIRE - Moderate Dosage
  • Usual & Customary Treatment (U&CT)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Sean Savitz specialize in?
Is Sean Savitz currently recruiting for clinical trials?
Are there any treatments that Sean Savitz has studied deeply?
What is the best way to schedule an appointment with Sean Savitz?
What is the office address of Sean Savitz?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security